MBX
Mbx Biosciences Inc
NASDAQ · Pharmaceuticals
$37.67
+1.62 (+4.49%)
Open$36.77
Previous Close$36.05
Day High$38.12
Day Low$36.63
52W High$44.89
52W Low$4.81
Volume—
Avg Volume768.6K
Market Cap1.69B
P/E Ratio—
EPS$-3.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+25.1% upside
Current
$37.67
$37.67
Target
$47.13
$47.13
$32.34
$47.13 avg
$55.83
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 515.19M | 454.58M | 572.08M |
| Net Income | 92.27M | 88.31M | 111.14M |
| Profit Margin | 17.9% | 19.4% | 19.4% |
| EBITDA | 143.26M | 124.50M | 146.54M |
| Free Cash Flow | 88.64M | 54.29M | 70.53M |
| Rev Growth | +6.8% | +2.6% | +10.2% |
| Debt/Equity | 1.22 | 1.24 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |